Planning Target Volume and Nodal Status Predict Clinical Outcomes After Chemoradiation and Durvalumab in Stage III Non‐Small Cell Lung Cancer by Ori Aslan, Johnathan Arnon, Itamar Averbuch, Daniel Reinhorn, Hovav Nechushtan, Yakir Rottenberg, Philip Blumenfeld

Get full text

Predictive value of ENLIGHT-DP in patients with metastatic lung adenocarcinoma treated with immune checkpoint inhibitors and platinum chemotherapy directly from histopathology slid... by Eli Pikarsky, Anna Elia, Gal Dinstag, Omer Tirosh, Tuvik Beker, Ranit Aharonov, Hovav Nechushtan, Leon Gugel, Yaron Kinar, Michael Tabi, Tzivia Gottlieb, Aron Popovtzer, Johnathan Arnon, Yakir Rottenberg, Philip Blumenfeld

Get full text

Efficacy and Safety of Metastatic Directed Treatment of Oligometastatic Disease: Results of a Meta-analysis by Yael Berner-Wygoda, MA, MD, Eitan Amir, MB ChB, PhD, Philip Blumenfeld, MD, Meredith Li, MD, Diego Malon, MBA, MD, Neha Pathak, MD, Jacqueline Savil, MN-RN, Yonaton Zarbiv, MD, Vikaash Kumar, MD

Get full text